# FDA recall D-0749-2022

> **DASH Pharmaceuticals LLC** · Class II · drug recall initiated 2022-03-11.

## Product

Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) and b) 100 case of 10 mL Unit Dose Cups (NDC 69339-148-19) Rx Only, Dash Pharmaceuticals, Upper Saddle River, NJ 07458.

## Reason for recall

Labeling: Label Mix-Up

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0749-2022
- **Recalling firm:** DASH Pharmaceuticals LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-03-11
- **Report date:** 2022-04-13
- **Termination date:** 2023-02-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Upper Saddle River, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0749-2022

## Citation

> AI Analytics. FDA recall D-0749-2022. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0749-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*